SCPS:OTC-Scopus Biopharma Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.0011

Change

0.00 (0.00)%

Market Cap

USD 0.05M

Volume

1.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-18 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
NONOF Novo Nordisk A/S

N/A

USD 599.53B
CSLLY CSL Ltd

N/A

USD 90.20B
CMXHF CSL Limited

N/A

USD 90.20B
UCBJF UCB SA

N/A

USD 26.60B
UCBJY UCB SA ADR

N/A

USD 26.44B
ARGNF argenx SE

N/A

USD 22.20B
GNMSF Genmab A/S

N/A

USD 18.02B
WXIBF WuXi Biologics

N/A

USD 7.05B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

USD 6.91B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 6.91B

ETFs Containing SCPS

IEO 18.73 % 0.42 %

N/A

N/A
IOGP:LSE iShares Oil & Gas Explora.. 10.76 % 0.00 %

N/A

USD 0.32B
SPOG:LSE iShares V Public Limited .. 10.76 % 0.00 %

N/A

USD 0.33B
IS0D:F iShares Oil & Gas Explora.. 10.32 % 0.00 %

N/A

USD 0.32B
IS0D:XETRA iShares Oil & Gas Explora.. 10.32 % 0.00 %

N/A

USD 0.32B
NRGD MicroSectors U.S. Big Oil.. 10.00 % 0.00 %

N/A

USD 0.08B
NRGU MicroSectors U.S. Big Oil.. 10.00 % 0.00 %

N/A

USD 1.94B
NRGO 10.00 % 0.00 %

N/A

N/A
NRGZ 10.00 % 0.00 %

N/A

N/A
YGRN 10.00 % 0.00 %

N/A

N/A
SXLE:LSE SPDR S&P U.S. Energy Sele.. 8.98 % 0.00 %

N/A

USD 0.83B
ZPDE:F SPDR S&P U.S. Energy Sele.. 8.98 % 0.00 %

N/A

USD 0.78B
ZPDE:XETRA SPDR® S&P® U.S. Energy .. 8.98 % 0.00 %

N/A

USD 0.78B
FRAK 8.73 % 0.54 %

N/A

N/A
IUES:LSE iShares S&P 500 Energy Se.. 8.22 % 0.00 %

N/A

USD 1.09B
IUSE:LSE iShares S&P 500 EUR Hedge.. 8.22 % 0.00 %

N/A

USD 5.70B
QDVF:F iShares S&P 500 Energy Se.. 8.22 % 0.00 %

N/A

USD 0.98B
QDVF:XETRA iShares S&P 500 Energy Se.. 8.22 % 0.00 %

N/A

USD 0.98B
IESU:LSE iShares S&P 500 Energy Se.. 8.18 % 0.00 %

N/A

USD 0.98B
XUEN:F Xtrackers (IE) Public Lim.. 8.18 % 0.00 %

N/A

USD 0.09B
XUEN:XETRA db x-trackers MSCI USA En.. 8.18 % 0.00 %

N/A

USD 0.09B
XSEN:LSE db x-trackers MSCI USA En.. 7.89 % 0.00 %

N/A

USD 0.08B
XUEN:LSE db x-trackers MSCI USA En.. 7.89 % 0.00 %

N/A

USD 0.08B
IYE iShares U.S. Energy ETF 7.64 % 0.42 %

N/A

USD 1.42B
JHME 6.90 % 0.48 %

N/A

N/A
FENY Fidelity® MSCI Energy In.. 6.89 % 0.08 %

N/A

USD 1.84B
NXF:CA First Asset Energy Giants.. 6.62 % 0.72 %

N/A

CAD 0.16B
NXF-B:CA CI Energy Giants Covered .. 6.62 % 0.00 %

N/A

CAD 0.02B
DIG ProShares Ultra Oil & Gas 6.55 % 0.95 %

N/A

USD 0.11B
DDG 5.83 % 0.95 %

N/A

N/A
DUG ProShares UltraShort Oil .. 5.83 % 0.95 %

N/A

USD 0.02B
WNRG:LSE SPDR MSCI World Energy UC.. 5.13 % 0.00 %

N/A

USD 0.59B
XDW0:LSE db x-trackers MSCI World .. 5.12 % 0.00 %

N/A

USD 1.16B
XDW0:F Xtrackers (IE) Public Lim.. 5.12 % 0.00 %

N/A

USD 1.07B
XDW0:XETRA db x-trackers MSCI World .. 5.12 % 0.00 %

N/A

USD 1.07B
FILL iShares MSCI Global Energ.. 4.87 % 0.39 %

N/A

USD 0.11B
5MVW:XETRA iShares MSCI World Energy.. 4.86 % 0.00 %

N/A

USD 0.59B
ERYY 4.79 % 0.45 %

N/A

N/A
HUL-U:CA 4.46 % 0.00 %

N/A

N/A
HUL:CA 4.46 % 2.20 %

N/A

N/A
GASX 4.29 % 1.01 %

N/A

N/A
IGE 4.16 % 0.46 %

N/A

N/A
FCUQ:CA Fidelity U.S. High Qualit.. 2.73 % 0.00 %

N/A

CAD 0.49B
FCQH:CA Fidelity U.S. High Qualit.. 2.64 % 0.43 %

N/A

CAD 0.05B
HEA:CA Horizons Enhanced Income .. 2.61 % 0.00 %

N/A

CAD 0.15B
HEA-U:CA Horizons Enhanced Income .. 2.61 % 0.00 %

N/A

CAD 0.03B
QDVB:F iShares IV Public Limited.. 2.46 % 0.00 %

N/A

USD 2.88B
QDVB:XETRA iShares Edge MSCI USA Qua.. 2.46 % 0.00 %

N/A

USD 2.88B
QUAL 2.23 % 0.15 %

N/A

N/A
IUQA:LSE iShares Edge MSCI USA Qua.. 2.17 % 0.00 %

N/A

USD 2.88B
IUQD:LSE iShares Edge MSCI USA Qua.. 2.17 % 0.00 %

N/A

USD 0.95B
IUQF:LSE iShares Edge MSCI USA Qua.. 2.17 % 0.00 %

N/A

USD 1.94B
GASL 1.45 % 1.19 %

N/A

N/A
TERM 0.88 % 0.64 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

N/A

USD 0.40B
BWX SPDR® Bloomberg Internat.. 0.00 % 0.50 %

N/A

USD 0.88B
EBND SPDR® Bloomberg Emerging.. 0.00 % 0.41 %

N/A

USD 1.98B
MTUM 0.00 % 0.15 %

N/A

N/A
TGED:CA TD Active Global Enhanced.. 0.00 % 0.00 %

N/A

CAD 0.27B
RYE 0.00 % 0.40 %

N/A

N/A
WIP SPDR® FTSE International.. 0.00 % 0.50 %

N/A

USD 0.40B
HPF:CA Energy Leaders Plus Incom.. 0.00 % 1.74 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -97.44% 4% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -97.44% 4% F 1% F
Trailing 12 Months  
Capital Gain -98.23% 6% D- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -98.23% 7% C- 3% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -63.09% 1% F N/A F
Dividend Return -63.09% 1% F N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.11% 71% C- 57% F
Risk Adjusted Return -153.48% 2% F 1% F
Market Capitalization 0.05M 15% F 9% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.